DexCom, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +16.1%
EBITDA: +51.4%
EBIT: +63.4%
EPS: +75.2%
Free cash flow: +148.5%
Operating cash flow: +84.9%

Forward estimates

Revenue: +14.8%
EBITDA: +31.5%
EPS: +14.2%

Three-year CAGR

Revenue: +17.0%
EBITDA: +33.9%
EBIT: +32.6%
Net income: +34.8%
EPS: +34.5%
Free cash flow: +52.3%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.